C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2011
05/26/2011	WO2011062909A2 Creating bioengineered lymph nodes
05/26/2011	WO2011062634A2 Monoclonal antibodies and diagnostic uses thereof
05/26/2011	WO2011062563A1 Modulators of cell cycle progression
05/26/2011	WO2011062561A1 The isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair.
05/26/2011	WO2011062559A1 Methods of enhancing pluripotentcy
05/26/2011	WO2011062313A1 Method for separating stem cells
05/26/2011	WO2011062298A1 System for increasing gene expression, and vector supporting said system
05/26/2011	WO2011062155A1 NUCLEIC ACID ENCODING MUTANT Gag PROTEIN
05/26/2011	WO2011062147A1 Method for inducing differentiation of dental pulp cells into odontoblasts
05/26/2011	WO2011062112A1 Highly-functional mutant of humanized anti-egfr antibody variable region
05/26/2011	WO2011062013A1 Inducer of selective differentiation into neural stem cells and/or neural precursor cells
05/26/2011	WO2011061937A1 Methods for producing antibody-producing cells that produce desired polypeptides
05/26/2011	WO2011061677A1 Method to prolong and improve the functionality of spermatozoa in vitro
05/26/2011	WO2011061656A1 Plants with increased yield
05/26/2011	WO2011061378A1 Development of bioactive electrospun coatings for biomedical applications
05/26/2011	WO2011061375A1 Implant composition for the regeneration of neural tissue, process of preparation and uses thereof
05/26/2011	WO2011061275A1 Production of glycoproteins with low n-glycolylneuraminic acid (neu5gc) content
05/26/2011	WO2011039584A3 Parstatin peptides
05/26/2011	WO2011032705A3 Three dimensional porous structures
05/26/2011	WO2011011468A3 Cell-mediated silica sol-gel encapsulation of living cells and tissues
05/26/2011	WO2011010966A8 Pre-natal mesenchymal stem cells
05/26/2011	WO2011008277A3 Hematopoietic stromal progenitor cells and uses thereof
05/26/2011	WO2010137036A3 Japanese encephalitis vaccine and method of manufacturing the same
05/26/2011	WO2010135603A3 Method for cancer detection, diagnosis and prognosis
05/26/2011	US20110126327 Herbicide resistant barley
05/26/2011	US20110126326 Strong activation domain
05/26/2011	US20110126325 Recombinant cells and methods for hydroxylating fatty acids
05/26/2011	US20110126324 Hypervirulent mutant of agrobacterium tumefaciens
05/26/2011	US20110126323 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
05/26/2011	US20110126316 Use of rice polypeptides/nucleic acids for plant improvement
05/26/2011	US20110126314 Modulation of coffee flavour precursor levels in green coffee grains
05/26/2011	US20110126313 Methods and compositions for modifying plant flavonoid composition and disease resistance
05/26/2011	US20110126310 Transgenic maize event mon 87427 and the relative development scale
05/26/2011	US20110126309 Methods and compositions for identifying downy mildew resistant cucumber plants
05/26/2011	US20110126308 Lettuce that is resistant to the lettuce aphid nasonovia ribisnigri biotype 1
05/26/2011	US20110126307 Chloroplast transit peptides for efficient targeting of dmo and uses thereof
05/26/2011	US20110126306 Circular Nucleic Acid Vectors, and Methods for Making and Using the Same
05/26/2011	US20110126305 Mutant blue fluorescent protein and method of using the same for fluorescence resonance energy transfer and blue fluorescent fish
05/26/2011	US20110126303 Modified Blood Clotting Factors And Methods Of Use
05/26/2011	US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females)
05/26/2011	US20110126301 Dendritic Cell Marker and Uses Thereof
05/26/2011	US20110125286 Multi-functional chamber for housing a biological component
05/26/2011	US20110124717 Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway
05/26/2011	US20110124711 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
05/26/2011	US20110124710 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
05/26/2011	US20110124709 Rna antagonists targeting gli2
05/26/2011	US20110124707 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell
05/26/2011	US20110124663 Substituted dioxopiperidines and dioxopyrrolidines as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
05/26/2011	US20110124641 Benzothiazole kinase inhibitors and methods of use
05/26/2011	US20110124615 Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
05/26/2011	US20110124607 Composition for regulation cellular senescence comprising lysophosphatidic acid and inhibitor of adenylyl cyclase as active ingredients
05/26/2011	US20110124602 Stat3 Inhibitor Having Anti-Cancer Activity and Methods
05/26/2011	US20110124599 2,4-Pyrimidinediamine Compounds and Prodrugs and Their Uses
05/26/2011	US20110124582 Novel polypeptide having anti-tumor activity
05/26/2011	US20110124580 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
05/26/2011	US20110124572 Syndecan-4 is a regulator of rac1-gtp
05/26/2011	US20110124567 Therapeutic compounds and methods
05/26/2011	US20110124565 Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives
05/26/2011	US20110124564 Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same
05/26/2011	US20110124556 Insulin and IGF-1 Receptor Agonists and Antagonists
05/26/2011	US20110124552 GMCSF and Truncated CCL2 Conjugates and Methods and Uses Thereof
05/26/2011	US20110124530 Pseudo-tissues and uses thereof
05/26/2011	US20110124516 Polymer Particles and Uses Thereof
05/26/2011	US20110124108 Epigenetic engineering
05/26/2011	US20110124107 Method of high frequency regeneration of sorghum
05/26/2011	US20110124106 Separation device
05/26/2011	US20110124105 Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing
05/26/2011	US20110124104 Inducing cell death by inhibiting adaptive heat shock response
05/26/2011	US20110124103 Macrocyclic derivative and assemblies formed therefrom
05/26/2011	US20110124102 Rage Fusion Proteins And Methods Of Use
05/26/2011	US20110124086 Hepatitis C Virus Culture System
05/26/2011	US20110124085 Unsymmetrical cyanine dimer compounds and their application
05/26/2011	US20110124084 Proteases
05/26/2011	US20110124078 Scalable cell culture bioreactor and cell culture process
05/26/2011	US20110124065 Cellular production of glucaric acid
05/26/2011	US20110124026 Multi-purpose substrates useful for cell culture and methods for making and using the same
05/26/2011	US20110124025 Cell Collecting Devices and Methods for Collecting Cells
05/26/2011	US20110123998 Materials and Methods for Treatment of Cancer
05/26/2011	US20110123636 Micellic assemblies
05/26/2011	US20110123596 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology
05/26/2011	US20110123591 Tumoricidal, bactericidal, or viricidal macrophage activation
05/26/2011	US20110123590 Selective Expansion of Regulatory T Cells
05/26/2011	US20110123572 Activated fibroblasts for treating tissue and/or organ damage
05/26/2011	US20110123567 Recombinant rift valley fever (rvf) viruses and methods of use
05/26/2011	US20110123566 Endogenous adjuvant molecules and uses thereof
05/26/2011	US20110123557 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1
05/26/2011	US20110123553 Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination
05/26/2011	US20110123552 Agonistic binding molecules to the human OX40 receptor
05/26/2011	US20110123551 Hvem/btla, hvem/cd 160 and hvem/gd cis complexes and methods of use
05/26/2011	US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
05/26/2011	US20110123536 Novel human anti-r7v antibodies and uses thereof
05/26/2011	US20110123533 Using EGFRvIII to Identify and Target Cancer Stem Cells
05/26/2011	US20110123532 Method for Making Heteromultimeric Molecules
05/26/2011	US20110123529 Single domain antibodies directed against epidermal growth factor receptor and uses therefor
05/26/2011	US20110123527 Method of generating single vl domain antibodies in transgenic animals
05/26/2011	US20110123522 Methods of treating cancer using anti cd24 antibodies
05/26/2011	US20110123520 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
05/26/2011	US20110123511 Method of Suppressing Gene Transcription Through Histone Lysine Methylation
05/26/2011	US20110123503 Platelet fraction deriving from placental blood
05/26/2011	US20110123502 Method for obtaining treg-cells

1 ... 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 ... 1827